Danaher Corporation (NYSE:DHR) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Danaher Corporation (NYSE:DHR) have been given a consensus recommendation of “Moderate Buy” by the twenty-three analysts that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and twenty have issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $253.8571.

Several research analysts recently commented on DHR shares. Guggenheim boosted their target price on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Robert W. Baird set a $251.00 price objective on Danaher in a research note on Thursday, January 29th. Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. Argus set a $265.00 price target on shares of Danaher in a research note on Wednesday, January 14th. Finally, TD Cowen reiterated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director owned 20,762 shares in the company, valued at $4,702,593. This represents a 13.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 over the last ninety days. Corporate insiders own 11.10% of the company’s stock.

Institutional Trading of Danaher

A number of large investors have recently bought and sold shares of DHR. Norges Bank acquired a new stake in shares of Danaher during the second quarter worth $1,979,503,000. Viking Global Investors LP boosted its stake in shares of Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the period. Generation Investment Management LLP increased its position in shares of Danaher by 56.2% in the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after buying an additional 1,787,522 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in shares of Danaher by 211.7% during the third quarter. Ameriprise Financial Inc. now owns 2,088,089 shares of the conglomerate’s stock valued at $414,038,000 after buying an additional 1,418,243 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $216.77 on Monday. The company has a market cap of $153.12 billion, a P/E ratio of 43.01, a PEG ratio of 2.91 and a beta of 0.91. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The firm’s 50 day moving average price is $229.62 and its 200 day moving average price is $214.88.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter last year, the company posted $2.14 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, research analysts forecast that Danaher will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is 25.40%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.